Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Marcocci

Showing results (71-80 of 209) with videos related to

Pageof 21
Sort By:
Endocrinology, Diabetes & Metabolism|March 1, 2019
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patientsDaniele Cappellani, Claudio Urbani, Chiara Sardella, et al.
The Journal of Clinical Endocrinology and Metabolism|May 2, 2013
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomasElena Pardi, Claudio Marcocci, Simona Borsari, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2024
Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid TumorigenesisElena Pardi, Anello Marcello Poma, Liborio Torregrossa, et al.
European Thyroid Journal|October 27, 2017
Does Graves' Orbitopathy Ever Disappear? Answers to an Old QuestionElena Sabini, Marenza Leo, Barbara Mazzi, et al.
European Thyroid Journal|October 12, 2019
Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the LiteratureAlessandro Brancatella, Nicola Viola, Sandra Brogioni, et al.
Endocrine|May 21, 2017
Clinical profile of juvenile primary hyperparathyroidism: a prospective studyFederica Saponaro, Claudio Marcocci, Federica Cacciatore, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2022
Insights Into the Role of DNA Methylation and Gene Expression in Graves OrbitopathyGiovanna Rotondo Dottore, Giulia Lanzolla, Simone Comi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Reasons for revision surgery after orbital decompression for Graves' orbitopathyStefano Sellari-Franceschini, Luca Muscatello, Veronica Seccia, et al.
Journal of Endocrinological Investigation|April 12, 2021
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective studyGiulia Lanzolla, Francesca Menconi, Francesca Nicolì, et al.
European Journal of Endocrinology|June 24, 2006
The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairmentElisabetta Cecconi, Maurizio Gasperi, Maura Genovesi, et al.
Pageof 21

Showing results (71-80 of 209) with videos related to

Sort By:
Pageof 21
Endocrinology, Diabetes & Metabolism|March 1, 2019
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patientsDaniele Cappellani, Claudio Urbani, Chiara Sardella, et al.
The Journal of Clinical Endocrinology and Metabolism|May 2, 2013
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomasElena Pardi, Claudio Marcocci, Simona Borsari, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2024
Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid TumorigenesisElena Pardi, Anello Marcello Poma, Liborio Torregrossa, et al.
European Thyroid Journal|October 27, 2017
Does Graves' Orbitopathy Ever Disappear? Answers to an Old QuestionElena Sabini, Marenza Leo, Barbara Mazzi, et al.
European Thyroid Journal|October 12, 2019
Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the LiteratureAlessandro Brancatella, Nicola Viola, Sandra Brogioni, et al.
Endocrine|May 21, 2017
Clinical profile of juvenile primary hyperparathyroidism: a prospective studyFederica Saponaro, Claudio Marcocci, Federica Cacciatore, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2022
Insights Into the Role of DNA Methylation and Gene Expression in Graves OrbitopathyGiovanna Rotondo Dottore, Giulia Lanzolla, Simone Comi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Reasons for revision surgery after orbital decompression for Graves' orbitopathyStefano Sellari-Franceschini, Luca Muscatello, Veronica Seccia, et al.
Journal of Endocrinological Investigation|April 12, 2021
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective studyGiulia Lanzolla, Francesca Menconi, Francesca Nicolì, et al.
European Journal of Endocrinology|June 24, 2006
The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairmentElisabetta Cecconi, Maurizio Gasperi, Maura Genovesi, et al.
Pageof 21